| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.75 | 0.005 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.61 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.4 | 6e-10 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.32 | 2e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.29 | 6e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.29 | 3e-11 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.28 | 5e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-11 |